American Journal of Epidemiology Advance Access originally published online on August 10, 2005
American Journal of Epidemiology 2005 162(6):548-558; doi:10.1093/aje/kwi248
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Colon Cancer in a Population-based, Case-Control Study of African Americans and Whites
1 Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD
2 Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC
3 Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC
4 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC
5 Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina, Chapel Hill, NC
Correspondence to Dr. Leah B. Sansbury, Center for Cancer Research, National Cancer Institute, 6116 Executive Boulevard, MSC 8235, Suite 702, Room 7215, Bethesda, MD 20892-8325 (e-mail: sansburl{at}mail.nih.gov).
African Americans have the highest colon cancer incidence and mortality rates among all US ethnic groups. Epidemiologic studies suggest that use of nonsteroidal antiinflammatory drugs (NSAIDs) is associated with a reduced risk of colon cancer, but no study to date with adequate sample size has reported on the association among African Americans. The authors examined the association between NSAID use and risk of colon cancer in a population-based, case-control study in North Carolina that enrolled 731 African-American (294 cases, 437 controls) and 960 White (349 cases, 611 controls) participants between 1996 and 2000. Odds ratios were calculated using unconditional logistic regression for categories of NSAIDs and colon cancer risk. Inverse associations between regular NSAID use and colon cancer were similar for African Americans (odds ratio = 0.41, 95% confidence interval: 0.22, 0.77) and Whites (odds ratio = 0.48, 95% confidence interval: 0.28, 0.83) but stronger for women than men. Inverse associations were slightly weaker for occasional versus regular NSAID use, but they were similar for aspirin and nonaspirin NSAID use. These results add new knowledge suggesting that the protective effect of NSAIDs against colon cancer is similar among African Americans and Whites.
African Americans; anti-inflammatory agents, non-steroidal; case-control studies; colonic neoplasms; European Continental Ancestry Group
Abbreviations: CI, confidence interval; COX-2, cyclooxygenase-2; MET, metabolic equivalent task; NSAID, nonsteroidal antiinflammatory drug
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Sharma and S. J D O'Keefe Environmental influences on the high mortality from colorectal cancer in African Americans Postgrad. Med. J., September 1, 2007; 83(983): 583 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bardia, J. O. Ebbert, R. A. Vierkant, P. J. Limburg, K. Anderson, A. H. Wang, J. E. Olson, C. M. Vachon, and J. R. Cerhan Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality J Natl Cancer Inst, June 6, 2007; 99(11): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Chan and C. S. Fuchs Long-term Use of Aspirin and Risk of Colorectal Cancer--Reply JAMA, December 28, 2005; 294(24): 3090 - 3091. [Full Text] [PDF]
|
|